Intravitreal Aflibercept for Retinal Angiomatous Proliferation : Results of a prospective case series at 96 weeks
| dc.contributor.author | Browning, Andrew C. | |
| dc.contributor.author | O'Brien, Jill M. | |
| dc.contributor.author | Vieira, Rute V. | |
| dc.contributor.author | Gupta, Rajen | |
| dc.contributor.author | Nenova, Kapka | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medical Statistics | en |
| dc.date.accessioned | 2019-06-13T08:50:05Z | |
| dc.date.available | 2019-06-13T08:50:05Z | |
| dc.date.issued | 2019 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 8 | |
| dc.format.extent | 245047 | |
| dc.identifier | 143382366 | |
| dc.identifier | fa15f827-dae1-456d-a2f1-d8dc5520fce8 | |
| dc.identifier | 85067003029 | |
| dc.identifier | 31163436 | |
| dc.identifier | 000492965000007 | |
| dc.identifier.citation | Browning, A C, O'Brien, J M, Vieira, R V, Gupta, R & Nenova, K 2019, 'Intravitreal Aflibercept for Retinal Angiomatous Proliferation : Results of a prospective case series at 96 weeks', Ophthalmologica, vol. 242, no. 4, pp. 239-246. https://doi.org/10.1159/000500203 | en |
| dc.identifier.doi | 10.1159/000500203 | |
| dc.identifier.iss | 4 | en |
| dc.identifier.issn | 0030-3755 | |
| dc.identifier.other | Mendeley: d6ffde97-8c5d-37bb-acdb-560a83032256 | |
| dc.identifier.uri | http://hdl.handle.net/2164/12386 | |
| dc.identifier.url | https://www.karger.com/Journal/Guidelines/224269#sec72 | en |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85067003029&partnerID=8YFLogxK | en |
| dc.identifier.url | http://www.mendeley.com/research/intravitreal-aflibercept-retinal-angiomatous-proliferation-results-prospective-case-series-96-weeks | en |
| dc.identifier.vol | 242 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Ophthalmologica | en |
| dc.subject | Retinal angiomatous proliferation | en |
| dc.subject | Neovascular age-related macular degeneration | en |
| dc.subject | Aflibercept | en |
| dc.subject | RISK-FACTORS | en |
| dc.subject | PHOTODYNAMIC THERAPY | en |
| dc.subject | MACULAR DEGENERATION | en |
| dc.subject | VERTEPORFIN | en |
| dc.subject | FELLOW EYE | en |
| dc.subject | NEOVASCULARIZATION | en |
| dc.subject | TRIAMCINOLONE | en |
| dc.subject | RANIBIZUMAB | en |
| dc.subject | GEOGRAPHIC ATROPHY | en |
| dc.subject | ENDOTHELIAL GROWTH-FACTOR | en |
| dc.subject | RE Ophthalmology | en |
| dc.subject | Sensory Systems | en |
| dc.subject | Ophthalmology | en |
| dc.subject.lcc | RE | en |
| dc.title | Intravitreal Aflibercept for Retinal Angiomatous Proliferation : Results of a prospective case series at 96 weeks | en |
| dc.type | Journal article | en |
